Search Results - "Journal of clinical and translational hepatology"

Refine Results
  1. 1
  2. 2

    Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022) by You, Hong, Wang, Fusheng, Li, Taisheng, Xu, Xiaoyuan, Sun, Yameng, Nan, Yuemin, Wang, Guiqiang, Hou, Jinlin, Duan, Zhongping, Wei, Lai, Jia, Jidong, Zhuang, Hui

    “…To facilitate the achieving of the goal of "eliminating viral hepatitis as a major public health threat by 2030" set by the World Health Organization, the…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Guidelines for Prevention and Treatment of Chronic Hepatitis B by Wang, Guiqiang, Duan, Zhongping

    “…To achieve the goal of the World Health Organization to eliminate viral hepatitis as a major public health threat by 2030, the Chinese Society of Infectious…”
    Get full text
    Journal Article
  5. 5

    Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma by Zhong, Bin-Yan, Jin, Zhi-Cheng, Chen, Jian-Jian, Zhu, Hai-Dong, Zhu, Xiao-Li

    “…Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. According to the Barcelona Clinic Liver Cancer (BCLC) staging system, transarterial…”
    Get full text
    Journal Article
  6. 6

    Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India by Kalal, Chetan R, Joshi, Harshad, Kumar, Vivek, Gopal, Divya, Rathod, Darshana, Shukla, Ashish, Gianchandani, Tarang, Bhatt, Chetan

    “…The impact of coronavirus disease-2019 (COVID-19) on liver function remains to be fully elucidated. This study was designed to investigate such and determine…”
    Get full text
    Journal Article
  7. 7

    Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD by Clare, Kathleen, Dillon, John F., Brennan, Paul N.

    “…The pathogenesis of metabolic-associated fatty liver disease (MAFLD) is complex and thought to be dependent on multiple parallel hits on a background of…”
    Get full text
    Journal Article
  8. 8

    Targeting the Wnt Signaling Pathway in Liver Fibrosis for Drug Options: An Update by Duspara, Kristina, Bojanic, Kristina, Pejic, Josipa Ivanusic, Kuna, Lucija, Kolaric, Tea Omanovic, Nincevic, Vjera, Smolic, Robert, Vcev, Aleksandar, Glasnovic, Marija, Curcic, Ines Bilic, Smolic, Martina

    “…Liver fibrosis is a life-threatening disease, with challenging morbidity and mortality for healthcare systems worldwide. It imparts an enormous economic burden…”
    Get full text
    Journal Article
  9. 9

    COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies by Feng, Gong, Zheng, Kenneth I, Yan, Qin-Qin, Rios, Rafael S, Targher, Giovanni, Byrne, Christopher D, Poucke, Sven Van, Liu, Wen-Yue, Zheng, Ming-Hua

    “…The outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has attracted increasing…”
    Get full text
    Journal Article
  10. 10

    Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease by Lin, Huapeng, Zhang, Xinrong, Li, Guanlin, Wong, Grace Lai-Hung, Wong, Vincent Wai-Sun

    “…Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is currently the most common chronic liver disease and affects at least a quarter of the global…”
    Get full text
    Journal Article
  11. 11

    Akkermansia muciniphila and Bifidobacterium bifidum Prevent NAFLD by Regulating FXR Expression and Gut Microbiota by Nian, Fulin, Wu, Longyun, Xia, Qiaoyun, Tian, Peiying, Ding, Chunmei, Lu, Xiaolan

    “…Non-alcoholic fatty liver disease (NAFLD) is closely associated with gut microbiota and has become the most common chronic liver disease worldwide, but the…”
    Get full text
    Journal Article
  12. 12

    Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver by Kaya, Eda, Yilmaz, Yusuf

    “…Nonalcoholic fatty liver disease (NAFLD) is a multisystemic clinical condition that presents with a wide spectrum of extrahepatic manifestations, such as…”
    Get full text
    Journal Article
  13. 13

    Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study by Yu, Cheng, Wang, Minzhen, Zheng, Shan, Xia, Miao, Yang, Hongyan, Zhang, Desheng, Yin, Chun, Cheng, Ning, Bai, Yana

    “…Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new concept, proposed in 2020; however, its applicability in Asia populations has yet to be…”
    Get full text
    Journal Article
  14. 14

    Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease by Li, Jie, Fan, Jian-Gao

    “…An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (2019 coronavirus disease, COVID-19) since December 2019, from Wuhan,…”
    Get full text
    Journal Article
  15. 15

    Statin-induced Liver Injury Patterns: A Clinical Review by Averbukh, Leon D., Turshudzhyan, Alla, Wu, David C., Wu, George Y.

    “…Since their introduction in 1987, hydroxymethyl glutaryl coenzyme A reductase (HMG-CoA) inhibitors, more commonly known as statins, have become some of the…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Persistently Rising Alpha-fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Review by Turshudzhyan, Alla, Wu, George Y

    “…Hepatocellular carcinoma (HCC), one of the most common malignant tumors worldwide, is known for its grim prognosis, with untreated life expectancy being only a…”
    Get full text
    Journal Article
  18. 18

    Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy by Deng, Zhu-Jian, Li, Le, Teng, Yu-Xian, Zhang, Yu-Qi, Zhang, Yu-Xin, Liu, Hao-Tian, Huang, Jian-Li, Liu, Zhen-Xiu, Ma, Liang, Zhong, Jian-Hong

    “…The proportions of patients with hepatocellular carcinoma (HCC) involving portal vein tumor thrombus (PVTT) varies greatly in different countries or regions,…”
    Get full text
    Journal Article
  19. 19

    Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome by Liu, Yimei, Liu, Ninghua, Liu, Yujing, He, Hongyu, Luo, Zhe, Liu, Wenjun, Song, Nan, Ju, Minjie

    “…Background and AimsThe effect of ginsenoside Rb1 on D-galactosamine (D-GalN)/lipopolysaccharide (LPS)-induced acute liver injury (ALI) is unknown. The aim of…”
    Get full text
    Journal Article
  20. 20